Does LENACAPAVIR Cause Injection site mass? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Injection site mass have been filed in association with LENACAPAVIR (Sunlenca). This represents 4.6% of all adverse event reports for LENACAPAVIR.
23
Reports of Injection site mass with LENACAPAVIR
4.6%
of all LENACAPAVIR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site mass From LENACAPAVIR?
Of the 23 reports.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENACAPAVIR. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does LENACAPAVIR Cause?
Off label use (95)
Injection site pain (58)
Injection site nodule (53)
Product use issue (49)
Labelled drug-drug interaction medication error (43)
Injection site discharge (41)
Product use in unapproved therapeutic environment (40)
Viral load increased (21)
Fatigue (20)
Death (18)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which LENACAPAVIR Alternatives Have Lower Injection site mass Risk?
LENACAPAVIR vs LENALIDOMIDE
LENACAPAVIR vs LENIOLISIB
LENACAPAVIR vs LENOGRASTIM
LENACAPAVIR vs LENVATINIB
LENACAPAVIR vs LEPONEX